뉴로핏 (Neurophet)

Neurophet is a South Korean startup, founded in 2016, focused on harnessing cutting-edge artificial intelligence (AI) technology to develop solutions for brain disorders. Led by CEO Jake Junkil Been and CTO Donghyeon Kim, the company's flagship products include the brain MRI imaging analysis software Neurophet AQUA, the PET scan analysis software Neurophet SCALE PET, and other innovative tools such as Neurophet tES/TMS Lab and Neurophet SegPlus for research purposes. In November 2023, Neurophet successfully secured a KRW20.00B Series C investment from a consortium of investors including the Industrial Bank of Korea, Mirae Asset Securities, DB Financial Investment, Quad Asset Management, Prophet Asset Management, KB Securities, Kolon Investment, Solidus Investment, Xoloninvest, and Seoil & M. The company's mission revolves around providing diagnosis support, treatment guidance, and therapeutic devices for individuals afflicted by brain diseases. By leveraging its deep expertise in neuroscience, Neurophet is committed to utilizing AI technology to advance research, diagnosis, and treatment in the field of neurology. With a strong emphasis on addressing critical brain health issues, Neurophet aims to pave the way for innovative solutions in the realm of brain disorders.